Saturday 17 October 2026
Export IMCC’s income statement to Excel — free account
IM Cannabis Corp.
IMCC Healthcare Drug Manufacturers Specialty & Generic
IM Cannabis Corp.’s revenue for fiscal 2025 (year ended December 2025) was $39.2 million, down 0.66% from fiscal 2024. In the quarter to June 2026, revenue fell 40.3%, EPS fell 385.7%, free cash flow fell 266.8% and total debt fell 64.7%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
1.36
0.03
+2.26%
Follow IMCC
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | — | 1 | 2 | 3 | 2 | 4 |
P/E ratio |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | — | — | 0.00 | 25.27 | 4.47 | 0.19 | 0.12 | 0.14 | 0.15 |
Altman Z-Score |
— | — | — | 92.07 | 8.62 | 1.40 | (6.18) | (7.12) | (8.96) | (11.69) |
P/FCF ratio |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.72 |
Altman Z″-Score (non-manufacturers) |
— | — | — | 4.07 | (0.16) | 1.89 | (15.73) | (19.14) | (25.14) | (32.65) |
Beneish M-Score |
— | — | — | — | (4.30) | 2.63 | (4.63) | (2.65) | (3.59) | (5.42) |
P/Operating CF |
— | — | — | (10.34) | (50.82) | 52.85 | (3.96) | (34.53) | (1.78) | 1.95 |
P/B ratio |
— | — | — | 0.79 | 31.92 | 1.18 | 0.43 | 0.43 | 2.38 | 0.00 |
Price to Tangible BV |
— | — | — | 0.83 | 35.89 | 4.60 | 1.66 | 0.00 | 0.00 | 0.00 |
EV/Sales |
— | — | — | 0.00 | 24.77 | 4.69 | 0.33 | 0.31 | 0.17 | 0.12 |
EV/EBITDA |
— | — | — | 0.00 | 24.77 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | — | — | 0.00 | (26.12) | (7.41) | (1.41) | (1.87) | (8.36) | 1.37 |
EV/FCF |
— | — | — | 0.00 | (26.12) | (6.54) | (1.27) | (1.75) | (7.92) | 1.36 |
Quick Ratio |
0.00 | 0.00 | 0.02 | 6.13 | 2.41 | 0.94 | 0.43 | 0.41 | 0.42 | 0.42 |
Current Ratio |
0.00 | 0.00 | 0.02 | 9.31 | 4.33 | 1.65 | 0.97 | 0.74 | 0.67 | 0.67 |
Net Debt/EBITDA |
(0.11) | (0.31) | 0.03 | 1.07 | 1.05 | (0.35) | (0.30) | 0.14 | (0.18) | 0.18 |
Debt/Assets |
1,666.67% | 0.00% | 0.00% | 3.40% | 2.62% | 10.13% | 16.62% | 0.81% | 6.21% | 4.91% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.04 | 0.08 | 0.14 | 0.42 | 0.03 | 0.77 | (0.43) |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.59 | 0.45 | 0.34 | 0.30 | 0.87 | 1.22 | 1.53 |
Operating CF/Net income |
0.58 | 0.00 | 0.77 | 0.82 | 0.28 | 1.94 | 0.07 | 0.85 | 0.10 | (0.42) |
Capex/Depreciation |
0.00 | — | — | 0.00 | (3.76) | (1.10) | (0.25) | (0.24) | (0.03) | (0.01) |
Interest Coverage |
(178.00) | (61.20) | (2,498.00) | (35.74) | (0.40) | (23.29) | (15.61) | (3.48) | (2.29) | (3.31) |
| (0.39%) | (0.14%) | (1.05%) | (41.07%) | (150.96%) | (16.39%) | (159.81%) | (49.46%) | (124.14%) | 5,561.96% | |
| (14,615.39%) | (11,376.00%) | (2,658.95%) | (47.19%) | (82.05%) | (11.00%) | (105.29%) | (16.99%) | (23.86%) | (31.57%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | (109.50%) | (11.05%) | (61.22%) | (65.10%) | (137.46%) | 0.00% |
Return on Tangible Assets |
10.96% | 3.66% | 27.36% | (27.94%) | (108.68%) | (28.04%) | (4,636.51%) | 272.54% | 135.29% | 149.84% |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 82.86 | 142.19 | 209.67 | 80.66 | 86.31 | 93.24 | 72.34 |
Research and Development Expense of Revenue |
— | — | — | 2.57% | 0.86% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 113.94% | 116.91% | 89.66% | 65.46% | 45.12% | 28.61% | 27.20% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.04 | 0.04 | 0.53 | 0.29 | 0.33 | 0.26 | 0.10 |
Share Based Compensation of Revenue |
— | — | — | 0.00% | 21.28% | 15.24% | 6.93% | 0.46% | 2.09% | 0.03% |
Graham Net Nets |
— | — | — | 0.99 | 0.00 | 0.01 | (0.42) | (1.84) | (1.69) | (1.53) |
Graham Number |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 155.52 |
Earnings Yield |
— | — | — | (5.38%) | (5.38%) | (5.69%) | (1,872.06%) | (163.72%) | (109.92%) | (140.68%) |
Free Cash Flow Yield |
— | — | — | 0.00% | (3.75%) | (16.05%) | (138.12%) | (147.16%) | (15.17%) | 57.99% |
Revenue per Share |
0.00 | 0.00 | 0.00 | 2.18 | 554.29 | 1,345.53 | 1,047.48 | 507.78 | 504.24 | 277.42 |
Operating CF per Share |
(0.01) | 0.00 | (0.26) | (1.43) | (276.24) | (851.72) | (243.68) | (84.02) | (10.05) | 23.90 |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | (94.53) | (113.86) | (26.07) | (6.04) | (0.56) | (0.07) |
Free Cash Flow per Share |
(0.01) | 0.00 | (0.26) | (1.43) | (370.77) | (965.58) | (269.74) | (90.06) | (10.61) | 23.84 |
Cash per Share |
0.00 | 0.00 | 0.01 | 3.35 | 310.57 | 422.07 | 47.21 | 18.86 | 8.65 | 16.77 |
Shareholders Equity per Share |
3.27 | 35.24 | 30.93 | 5.93 | 439.88 | 5,078.43 | 458.76 | 142.54 | 29.36 | (18.32) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
3.27 | 35.24 | 30.93 | 5.93 | 439.88 | 5,078.43 | 458.76 | 142.54 | 29.36 | (18.32) |
Free Cash Flow |
(0.02) | — | (0.07) | (4.58) | (7.93) | (31.09) | (10.76) | (6.41) | (0.83) | 3.37 |
Working Capital |
(0.31) | (0.35) | (0.34) | 16.68 | 15.58 | 26.40 | (0.88) | (6.33) | (8.43) | (8.06) |
Capital Expenditures |
— | — | — | (1.19) | (2.02) | (3.67) | (1.04) | (0.43) | (0.04) | (0.01) |
Net Current Asset Value |
(0.31) | (0.35) | (0.34) | 15.00 | 1.22 | 1.49 | (3.24) | (8.04) | (9.25) | (9.02) |
EV/EBIT |
— | — | — | 0.00 | 24.77 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
— | — | — | 0.00 | 0.17 | 0.08 | 0.02 | 0.01 | 0.00 | 0.00 |
Price to Operating Income |
— | — | — | 0.00 | 25.27 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.00 | — | — | 0.14 | 0.13 | 0.14 | 1.03 | 0.47 | 0.49 | 0.44 |
Cash ROIC |
(0.23%) | 0.00% | (0.85%) | (15.03%) | (47.21%) | (15.52%) | (38.51%) | (54.42%) | (17.47%) | 375.62% |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 8.79 | 3.82 | 2.94 | 2.45 | 4.07 | 4.23 | 4.39 |
Accounts Payable Turnover |
0.00 | — | — | 6.09 | 3.90 | 5.16 | 2.89 | 3.10 | 4.44 | 3.84 |
Inventory Turnover |
0.00 | — | — | 1.09 | 0.85 | 2.18 | 1.76 | 2.86 | 6.83 | 11.94 |
Average Days of Payables |
0.00 | — | — | 32.52 | 134.28 | 120.37 | 129.84 | 86.41 | 89.36 | 97.68 |
Days of Inventory on Hand |
0.00 | — | — | 263.51 | 435.46 | 267.42 | 140.64 | 93.47 | 25.75 | 34.58 |
Average Receivables |
0.00 | 0.00 | 0.00 | 0.79 | 3.10 | 14.75 | 17.06 | 8.89 | 9.31 | 8.92 |
Average Payables |
— | — | — | 1.41 | 1.35 | 6.55 | 11.47 | 9.31 | 7.49 | 8.39 |
Average Inventory |
— | — | — | 7.84 | 6.25 | 15.55 | 18.78 | 10.07 | 4.87 | 2.70 |
Average Assets |
0.00 | 0.00 | 0.00 | 11.89 | 26.11 | 128.88 | 137.99 | 41.42 | 32.38 | 25.66 |
Average Common Equity |
8.77 | 8.77 | 8.72 | 13.66 | 14.19 | 86.47 | 90.92 | 14.23 | 6.22 | (0.15) |
Columns are period end dates